Adherence to Diabetes Medications and Health Care Use During the COVID-19 Pandemic Among High-Risk Patients

References

1. 1.↵
   1. Boersma P,
   2. Black LI,
   3. Ward BW

   . Peer reviewed: prevalence of multiple chronic conditions among US adults, 2018. Prev Chronic Dis 2020;17:E106.

   OpenUrl
2. 2.↵
   1. Yoon J,
   2. Zulman D,
   3. Scott JY,
   4. Maciejewski ML

   . Costs associated with multimorbidity among VA patients. Medical Care 2014;52:S31–S36.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Heyworth L,
   2. Kirsh S,
   3. Zulman D,
   4. Ferguson JM,
   5. Kizer KW

   . Expanding access through virtual care: the VA’s early experience with Covid-19. N Engl J Med Catalyst Innovations in Care Delivery 2020;1:1.

   OpenUrl
4. 4.↵
   1. Baum A,
   2. Kaboli PJ,
   3. Schwartz MD

   . Reduced in-person and increased telehealth outpatient visits during the COVID-19 pandemic. Ann Intern Med 2021;174:129–31.

   OpenUrlPubMed
5. 5.↵
   1. Reddy A,
   2. Gunnink E,
   3. Deeds SA,
   4. et al

   . A rapid mobilization of “virtual” primary care services in response to COVID-19 at Veterans Health Administration. Healthc (Amst) 2020;8:100464.

   OpenUrl
6. 6.↵
   1. Patel SY,
   2. Mehrotra A,
   3. Huskamp HA,
   4. Uscher-Pines L,
   5. Ganguli I,
   6. Barnett ML

   . Variation in telemedicine use and outpatient care during the COVID-19 pandemic in the United States. Health Aff (Millwood) 2021;40:349–58.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Whaley CM,
   2. Pera MF,
   3. Cantor J,
   4. et al

   . Changes in health services use among commercially insured US populations during the COVID-19 pandemic. JAMA Netw Open 2020;3:e2024984.

   OpenUrl
8. 8.↵
   1. Wang L,
   2. Porter B,
   3. Maynard C,
   4. et al

   . Predicting risk of hospitalization or death among patients receiving primary care in the Veterans Health Administration. Medical Care 2013;51:368–73.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Ferguson JM,
   2. Jacobs J,
   3. Yefimova M,
   4. Greene L,
   5. Heyworth L,
   6. Zulman DM

   . Virtual care expansion in the Veterans Health Administration during the COVID-19 pandemic: clinical services and patient characteristics associated with utilization. J Am Med Inform Assoc 2021;28:453–62.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Nau DP

    . Proportion of days covered (PDC) as a preferred method of measuring medication adherence [Internet]. 2012. Available from: https://www.researchgate.net/publication/273505401_Cost-effectiveness_Analysis_of_LDL_cholesterol-Lowering_Therapy_in_Hypertensive_Patients_with_Type-2_Diabetes_in_Korea_Single-Pill_Regimen_AmlodipineAtorvastatin_versus_Double-Pill_Regimen_Amlodipine_.
11. 11.↵
    1. Yoon J,
    2. Wu F,
    3. Chang E

    . Impact of primary care intensive management on medication adherence and adjustments. Am J Manag Care 2020;26:e239–e245.

    OpenUrl
12. 12.↵
    Clinical Classifications Software for ICD-10-CM [software]. 2020.
13. 13.↵
    1. Elixhauser A,
    2. Steiner C,
    3. Harris DR,
    4. Coffey RM

    . Comorbidity measures for use with administrative data. Medical Care 1998;36:8–27.

    OpenUrlCrossRefPubMedWeb of Science
14. 14.↵
    United States COVID-19 Community Levels by County [Internet]. 2021 [cited 2022 March 1]. Available from: https://data.cdc.gov/Public-Health-Surveillance/United-States-COVID-19-Community-Levels-by-County/3nnm-4jni.
15. 15.↵
    1. Kerr EA,
    2. Fleming B

    . Making performance indicators work: experiences of US Veterans Health Administration. BMJ 2007;335:971–3.

    OpenUrlFREE Full Text
16. 16.↵
    1. Elnahal SM,
    2. Clancy CM,
    3. Shulkin DJ

    . A framework for disseminating clinical best practices in the VA health system. JAMA 2017;317:255–6.

    OpenUrlPubMed
17. 17.↵
    1. Jha AK,
    2. Perlin JB,
    3. Kizer KW,
    4. Dudley RA

    . Effect of the transformation of the Veterans Affairs health care system on the quality of care. N Engl J Med 2003;348:2218–27.

    OpenUrlCrossRefPubMedWeb of Science
18. 18.↵
    1. Darkins A

    . The growth of telehealth services in the Veterans Health Administration between 1994 and 2014: a study in the diffusion of innovation. Telemed J E Health 2014;20:761–8.

    OpenUrlCrossRefPubMed
19. 19.↵
    1. Kini V,
    2. Ho PM

    . Interventions to improve medication adherence: a review. JAMA 2018;320:2461–73.

    OpenUrlPubMed
20. 20.↵
    1. Bailey ZD,
    2. Krieger N,
    3. Agénor M,
    4. Graves J,
    5. Linos N,
    6. Bassett MT

    . Structural racism and health inequities in the USA: evidence and interventions. Lancet 2017;389:1453–63.

    OpenUrlCrossRefPubMed
21. 21.↵
    1. Yearby R,
    2. Clark B,
    3. Figueroa JF

    . Structural racism in historical and modern US health care policy. Health Aff (Millwood) 2022;41:187–94.

    OpenUrlCrossRefPubMed
22. 22.↵
    1. Aubert CE,
    2. Henderson JB,
    3. Kerr EA,
    4. Holleman R,
    5. Klamerus ML,
    6. Hofer TP

    . Type 2 diabetes management, control and outcomes during the COVID-19 pandemic in older US veterans: an observational study. J Gen Intern Med 2022;37:870–7.

    OpenUrl
23. 23.↵
    1. Baum A,
    2. Schwartz MD

    . Admissions to Veterans Affairs hospitals for emergency conditions during the COVID-19 pandemic. JAMA 2020;324:96–9.

    OpenUrlPubMed
24. 24.↵
    1. Pagán VM,
    2. McClung KS,
    3. Peden CJ

    . An observational study of disparities in telemedicine utilization in primary care patients before and during the COVID-19 pandemic. Telemed J E Health 2022;28:1117–25.

    OpenUrl
25. 25.↵
    1. Alexander GC,
    2. Tajanlangit M,
    3. Heyward J,
    4. Mansour O,
    5. Qato DM,
    6. Stafford RS

    . Use and content of primary care office-based vs telemedicine care visits during the COVID-19 pandemic in the US. JAMA Netw Open 2020;3:e2021476.

    OpenUrl
26. 26.↵
    1. Chen JL,
    2. Krupp GR,
    3. Lo JY

    . The COVID-19 pandemic and changes in health care utilization among patients with type 2 diabetes. Diabetes Care 2022;45:e74.

    OpenUrl
27. 27.↵
    1. Nielsen VM,
    2. Song G,
    3. Ojamaa LS,
    4. Blodgett RP,
    5. Rocchio CM,
    6. Pennock JN

    . The COVID-19 pandemic and access to selected ambulatory care services among populations with severely uncontrolled diabetes and hypertension in Massachusetts. Public Health Rep 2022;137:344–51.

    OpenUrl
28. 28.↵
    1. Sharma A,
    2. Greene DN,
    3. Chambliss AB,
    4. et al

    . The effect of the Covid-19 shutdown on glycemic testing and control. Clin Chim Acta 2021;519:148–52.

    OpenUrl
29. 29.↵
    1. Ramey OL,
    2. Silva Almodóvar A,
    3. Nahata MC

    . Medication adherence in Medicare-enrolled older adults with asthma before and during the coronavirus disease 2019 pandemic. Ann Allergy Asthma Immunol 2022;128:561–7.

    OpenUrl
30. 30.↵
    1. Clement J,
    2. Jacobi M,
    3. Greenwood BN

    . Patient access to chronic medications during the Covid-19 pandemic: evidence from a comprehensive dataset of US insurance claims. PLoS ONE 2021;16:e0249453.

    OpenUrlPubMed
31. 31.↵
    1. Agha Z,
    2. Lofgren RP,
    3. VanRuiswyk JV,
    4. Layde PM

    . Are patients at Veterans Affairs medical centers sicker? A comparative analysis of health status and medical resource use. Arch Intern Med 2000;160:3252–7.

    OpenUrlCrossRefPubMedWeb of Science
32. 32.↵
    1. Rogers WH,
    2. Kazis LE,
    3. Miller DR,
    4. et al

    . Comparing the health status of VA and non-VA ambulatory patients: the veterans' health and medical outcomes studies. J Ambul Care Manage 2004;27:249–62.

    OpenUrlCrossRefPubMed
33. 33.↵
    1. Wong ES,
    2. Guo R,
    3. Yoon J,
    4. et al

    . Impact of VHA's primary care intensive management program on dual system use. Healthc (Amst) 2020;8:100450.

    OpenUrl